BioSwift Talent’s Post

Big news for little hearts💞! FDA expands use of Johnson & Johnson Impella heart pumps for pediatric patients suffering from acute heart failure and cardiogenic shock.

Exciting News! Our latest whitepaper, "How Pediatric Patients Benefit from An Integrated Specialty Pharmacy Care Model" is out now! In today's healthcare landscape, providing comprehensive care for pediatric patients is paramount. Our whitepaper delves into key concepts that highlight the importance of an integrated specialty pharmacy care model for the well-being of our youngest patients. Download your copy today and be part of the conversation shaping the future of pediatric healthcare - https://lnkd.in/gQ-4UrGB #ElevatingSpecialtyPharmacy #HealthcareInnovation #PediatricPatients

A big shout out to CPESN Networks with the highest network performance on Seguridad, Inc's Assessment of Weights in Pediatrics pharmacy quality measure. A CPESN Networks pharmacy identified and resolved medication errors discussed in the article. #Patientsafety #Pharmacyqualitymeasurement #Pharmacysafety

Looking to enhance diversity in your clinical trial? We just achieved 100% diverse enrollment in our latest pediatric vaccine trial. Let's collaborate to ensure your studies reflect a broad and inclusive participant base. Reach out to us today! #DiversityInResearch #ClinicalTrials #InclusiveResearch #PediatricVaccine #HealthEquity #MedicalResearch #DiversityMatters #ClinicalTrialDiversity

The US FDA has expanded the indications for the Johnson & Johnson Impella 5.5 and Impella CP heart pumps, granting premarket approval for use in specific paediatric patients with symptomatic acute decompensated heart failure and cardiogenic shock https://lnkd.in/ee4CnueZ

Micro blood sampling is extremely easy now.

For your pediatric patients, only the best will do. But using scaled-down versions of adult endotracheal tubes on children can introduce unintended risks.(1) Only Shiley™ pediatric endotracheal tubes with TaperGuard™ cuff technology can help put you in a better position to minimize the potential for airway damage, oxygen deprivation, and ventilation complications in your pediatric patients.(1,2) https://bit.ly/4d1BhV4

Our team of 28 pediatric board-certified physicians brings a wealth of experience and a deep understanding of pediatric regulations, ethical considerations and patient-centric approaches to every trial we undertake. From protocol design to site selection, patient recruitment and data management, we prioritize safety, efficacy and ethical conduct at every step of the process. #pediatricresearch #drugdevelopment #clinicaltrials

Investigational Use Only Pediatric sampling just got easier with RedDrop ONE! 🌟 Designed to prioritize comfort and convenience, RedDrop ONE transforms blood collection for research involving children: ✅ Painless Collection: Eliminates needle phobia, offering a stress-free experience for young participants. ✅ Reduced Blood Volume Needs: Addresses concerns about sample reliability while using less blood. This innovative solution ensures a smoother and more comfortable process for pediatric patients, paving the way for groundbreaking research with minimal stress. Learn more about how RedDrop ONE is changing the game in pediatric research. https://lnkd.in/gxB9h-dK

The design of pediatric trials must take into consideration special protections for the safety of this vulnerable population, the normal growth and development that children will undergo during the study period and the patient and caregiver experience as they progress from recruitment through trial completion. In this article, we will discuss the nuances of pediatric trials.